GLP1R and type 2 diabetes mellitus: Among the patients with type 2 diabetes, those with history of taking SU and AGi did not have an increased risk of idiopathic cardiomyopathy, whereas those with a history of taking metformin, meglitinides, TZD, DPP-4i, SGLT-2i, or GLP-1 had lowered risk.